Affluense AI AFFLUENSE

Pharma and Healthcare

Kotak Mahindra Asset Management Company Ltd
PMS Sector Fund
Benchmark
Nifty 50 TRI
Inception Date
20 September 2016
Min. Investment
₹50,00,000
AUM (Cr.)
₹21.44
SIP Available
No
STP Available
Yes

Investment Strategy

Investment Approach

The Investment approach will invest in all equity and equity related instruments with emphasis on capturing available opportunities in Pharma and Health care related stocks

Investment Objective

The main objective of the Investment approach is to generate capital appreciation through investments in equities with a medium to long-term perspective.

Performance Returns

Returns as on 2025-12-31

Trailing Returns

Period Strategy Benchmark Outperformance
1 MONTH -5.66% -0.28% -5.38%
3 MONTHS -4.86% 6.33% -11.19%
6 MONTHS -3.14% 2.92% -6.06%
1 YEAR -8.53% 11.88% -20.41%
2 YEAR 10.44% 10.97% -0.53%
3 YEAR 17.57% 14.31% 3.26%
5 YEAR 12.26% 14.67% -2.41%
SINCE INCEPTION 12.24% 13.78% -1.54%

Calendar Year Performance

Year Return
CY 2025 -8.53%
CY 2024 33.38%
CY 2023 33.25%
CY 2022 -12.29%
CY 2021 25.07%
CY 2020 60.01%
CY 2019 0.53%
CY 2018 -4.95%
CY 2017 10.64%
CY 2016 -3.14%

Financial Year Performance

Year Return
FY 26_YTD 1.74%
FY 25 9.05%
FY 24 53.48%
FY 23 -11.42%
FY 22 21.48%
FY 21 67.56%
FY 20 -8.56%
FY 19 8.81%
FY 18 -4.65%
FY 17 0.96%

Past performance is not indicative of future results. Returns are subject to market risks.

Fund Managers

Brijesh Ved

Principal Officer & Head- PMS

Over 23 years of professional work experience, of which he has spent 20 years in Asset Management Industry in India. At presently he works with Kotak AMC, as Head of Discretionary PMS. He comes with strong funds management & equity research background.He has spent two stints at Enam Asset Management (AMC) between 2004 to 2015 and 2021 to 2024. Before Enam AMC, he was with BNP Paribas Asset Management as Head of Equities- Offshore Advisory & PMS between 2015 to 2021.He holds an MBA in Finance from Monash Mt. Eliza Business School, Australia and a Bachelor of Commerce from the University of Mumbai.

Portfolio Details

Portfolio Composition

Large Cap
0.00%
Mid Cap
24.06%
Small Cap
75.61%
Cash & Equivalent
0.33%

Top 5 Holdings

  • Aster Dm Healthcare Ltd 28.98%
  • Fortis Healthcare Ltd 24.06%
  • Emcure Pharmaceuticals Ltd 23.74%
  • Piramal Pharma Ltd 15.47%
  • Laxmi Dental Ltd 7.43%

Top 5 Sectors

  • Healthcare Services 53.03%
  • Pharma & Biotech 39.21%
  • Healthcare Equipment & Supplies 7.43%

Portfolio Characteristics

total number of stocks
19
top 5 stocks percent
99.68%
top 5 sectors percent
99.67%
average market cap
35227.35
portfolio age
9 Yrs, 3 Months
sip
Not Available
stp
Available

Fee Structure

Fixed Fee

AMC: 2.5%

Variable Fee

AMC: 1.5%

Hurdle: 10%

Profit Sharing: 20%

Exit Load

Year 1: 1%

Year 2: 0%

Year 3: 0%

Disclaimer

* Returns are as on31st December 2025 , * Returns over a 1 year period are annualized * Returns are calculated using the Time Weighted Rate of Return (TWRR) method and as provided by the respective AMCs. *ND (No Data) , * NA(Not Applicable) * Returns of the respective Benchmark Indices used are tabulated above. Benchmark(s) given are as per SEBI circular no. SEBI/HO/IMD/IMD-PoD-2/P/CIR/2022/172 dated December 16, 2022 and the APMI circular no. APMI/2022-23/02 dated 23rd March,2023 and Revised Annexure-1

This profile is provided for general informational purposes only and is based on publicly available information. While reasonable care is taken, the content may not always reflect the latest updates.

Nothing on this page constitutes investment, financial, or legal advice. Investment decisions should be made after consulting a qualified advisor and reviewing official scheme documents.

Affluense AI – Smarter Insights. Stronger Relationships with Affluents.

Last Updated: January 2026 · Published by Affluense AI (affluense.ai)

© 2026 Affluense AI